ASH 2013: Dr. Adrian Wiestner Discusses Progno... - CLL Support

CLL Support

22,456 members38,597 posts

ASH 2013: Dr. Adrian Wiestner Discusses Prognostic and Predictive Factors, the Nuances of 17p deletion and Residual Disease

bkoffman profile image
bkoffmanCLL CURE Hero
1 Reply

Friends,

In my blog bkoffman.blogspot.com I have posted the second part of Dr. Wiestner's interview that addresses some of the subtleties of CLL that we are gradually beginning to understand from the research begin done by his team at the NIH and others around the world.

We are moving the needle, but it is still not pointing at cure.

Stay strong. Merry Christmas.

Brian

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
1 Reply
jangreen profile image
jangreen

Hi I think a lot of important issues are raised in this interview.One about long term. But no one has a crystal ball. Best wishes

You may also like...

ASH 2013: Dr. John Pagel Discusses Radio-Immune Therapy (RIT) in Chronic Lymphocytic Leukemia (CLL)

In another interview from ASH 2013 that I just posted on my blog http://bkoffman.blogspot.com , Dr....

ASH 2014. Dr. Sharman discusses the biology of our CLL cells

week on the CLL Society website http://cllsociety.org, we share the first part of an interview from...

Excited to see some of you in Cambridge

how we can work together. It's the beginning of a borderless CLL community. You can play a role....

Husband beginning V+O treatment for unmutated CLL

expect when treatment begins. He will have a 1-2 night hospital stay when he begins the Ventoclax,...

Fewer antibodies with second test

Took my second Antibody test ; while I'm happy I still have antibodies (they were very low to begin...